drugset / Trial / NCT07262554

N-acetylcysteine for Root Canal Treatment of Necrotic Teeth With Apical Periodontitis

NCT07262554

Phase 2 Active not recruiting 40 enrolled Alexandria University
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized controlled trial comparing the postoperative pain intensity, periapical biomarkers level, and periapical healing in patients with necrotic mature teeth and apical periodontitis treated with N-acetylcysteine (NAC), as an intracanal and adjunctive systemic medication, versus calcium hydroxide (Ca(OH)₂) intracanal medication alone.

Timeline

Start
2025-11-15
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Hydroxide Other / unclassified Other
Subject N-acetylcysteine Small molecule 600 mg Other

Indications